Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Takeda Pharmaceutical Co., Ltd. (4502)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,136.0 -20.0    -0.63%
01:00:00 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3463000004 
  • Volume: 7,146,700
  • Bid/Ask: 3,131.0 / 3,136.0
  • Day's Range: 3,122.0 - 3,162.0
Takeda Pharmaceutical 3,136.0 -20.0 -0.63%
Dean Popplewell
Italian Politics Weigh On The Euro By Dean Popplewell - May 08, 2018

Tuesday May 8: Five things the markets are talking about Capital markets are back to full capacity after yesterday’s May Day celebrations in parts of Europe. Euro stocks are drifting lower...

IFC Markets
Continued Tech Sell Off Leads U.S. Markets Lower By IFC Markets - Mar 29, 2018

Higher consumer spending boosts Q4 GDP US stocks extended losses on Wednesday as the technology stocks selloff continued. The S&P 500 lost 0.3% to 2605. The Dow Jones industrial slipped 0.1% to...

London Capital Group
Dumping Regulation, Strained Tech For M&A-Fuelled Healthcare By London Capital Group - Mar 28, 2018

A higher revision to earlier estimates of fourth quarter US economic growth and more signs of easing geopolitical tensions on the Korean Peninsula have helped to ease some nerves. The tide of selling...

Samuel Rae
Here's What The Takeda Deal Means For the Healthcare By Samuel Rae - Nov 08, 2017

Takeda Pharmaceutical (T:4502) just announced that it has teamed up with privately held Portal Instruments. Markets are relatively flat on the news, which isn’t overly surprising given the early...

Edison
Orexigen Therapeutics: Contrave Rebounds   By Edison - Jun 16, 2017

Orexigen Therapeutics (NASDAQ:OREX) consumer-focused re-launch of Contrave continues to be successful with a 39% increase in prescriptions in the United States in Q117 compared to Q416. Outside of the...

Marvin Clark
Stocks Temper New Year Momentum By Marvin Clark - Jan 11, 2017

U.S. equities finished mixed, softening from their bull run to start the New Year, as strength in technology issues was met with weakness in financials and energy issues as Treasury yields saw some...

Ticker.tv News
XBiotech Inc Shares Crash Down On Cancer Drug Trial Res By Ticker.tv News - Jul 06, 2016

XBiotech Inc (NASDAQ:XBIT) XBiotech Inc, a clinical stage biopharmaceutical company saw stock prices crash on cancer drug trial results. Results were cloudy due to the tricky wording of the trial...

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4502 Comments

Write your thoughts about Takeda Pharmaceutical Co., Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email